59 results
DEFA14A
ABOS
Acumen Pharmaceuticals Inc
22 Apr 24
Additional proxy soliciting materials
4:31pm
the 2027 Annual Meeting of Stockholders. 1.01 Daniel O'Connell 1.02 Nathan Fountain, M.D. 2. To ratify the selection by the Audit Committee of the Board
8-K
nkdikvehkmpxwo
19 Mar 24
Corporate Presentation March 2024 1
8:05am
424B5
pq4qqnl8616u8wt
20 Jul 23
Prospectus supplement for primary offering
4:11pm
8-K
EX-1.1
av69iz ml
20 Jul 23
Entry into a Material Definitive Agreement
4:06pm
424B5
y4b0x2vm
17 Jul 23
Prospectus supplement for primary offering
4:49pm